alendronate has been researched along with metformin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hussar, DA | 1 |
| Agabiti-Rosei, E; Colombo, GL; Margonato, A; Mencacci, C; Montecucco, CM; Trevisan, R | 1 |
| Li, Q; Li, Y; Meng, Y; Shi, D; Zhang, H; Zhao, J; Zuo, L | 1 |
| Alencar, MS; Alves, EHP; Araújo, AJ; Araújo, AR; Filho, JDBM; Iles, B; Leal, LKAM; Lopes, ALF; Medeiros, JVR; Nolêto, IRSG; Oliveira, AP; Pacheco, G; Sousa, FBM; Vasconcelos, DFP | 1 |
| Asch, AS; Kumar, G; Lightfoot, S; Madka, V; Mohammed, A; Pathuri, G; Rao, CV; Steele, VE; Zhang, Y | 1 |
| Chen, H; Guan, Z; Han, G; Jin, X; Liu, S; Tao, K; Xuan, Y; Zhou, Q | 1 |
| Apostolova, D; Batsalova, T; Belenska-Todorova, L; Dzhambazov, B; Georgieva, E; Ivanovska, N; Lambova, SN; Moten, D; Stoyanova, S | 1 |
1 review(s) available for alendronate and metformin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for alendronate and metformin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
New therapeutic agents marketed in 1995.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acarbose; Alendronate; Anti-Inflammatory Agents; Anti-Ulcer Agents; Carbonic Anhydrase Inhibitors; Drug Approval; Enzyme Inhibitors; Hypoglycemic Agents; Lansoprazole; Metformin; Omeprazole; Pregnadienes; Sulfonamides; Thiophenes; Trisaccharides; United States; United States Food and Drug Administration | 1996 |
Off-patent generic medicines vs. off-patent brand medicines for six reference drugs: a retrospective claims data study from five local healthcare units in the Lombardy Region of Italy.
Topics: Alendronate; Amlodipine; Drugs, Generic; Humans; Italy; Metformin; Nonprescription Drugs; Propafenone; Retrospective Studies; Sertraline | 2013 |
Preventative effects of metformin on glucocorticoid-induced osteoporosis in rats.
Topics: Alendronate; Animals; Blood Glucose; Body Weight; Bone Density; Female; Femur; Glucocorticoids; Lipids; Lumbar Vertebrae; Metformin; Methylprednisolone; Osteocalcin; Osteoporosis; Protective Agents; Rats, Sprague-Dawley; Tartrate-Resistant Acid Phosphatase | 2019 |
Alendronate-induced gastric damage in normoglycemic and hyperglycemic rats is reversed by metformin.
Topics: Alendronate; Animals; Blood Glucose; Collagen; Cytokines; Cytoprotection; Gastric Mucosa; Hyperglycemia; Malondialdehyde; Metformin; Peroxidase; Rats; Rats, Wistar; Stomach | 2019 |
Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model.
Topics: Administration, Oral; Alendronate; Animals; Anticarcinogenic Agents; Apoptosis; Azoxymethane; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Male; Metformin; Neoplasms, Experimental; Rats; Rats, Inbred F344; Zoledronic Acid | 2020 |
The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice.
Topics: Alendronate; Animals; Blood Glucose; Bone Demineralization, Pathologic; Bone Density; Bone Density Conservation Agents; Diabetes Mellitus; Drug Therapy, Combination; Female; Glucose; Hypoglycemic Agents; Metformin; Mice; Mice, Inbred NOD | 2022 |
Changes in the Subchondral Bone, Visfatin, and Cartilage Biomarkers after Pharmacological Treatment of Experimental Osteoarthritis with Metformin and Alendronate.
Topics: Alendronate; Animals; Biomarkers; Cartilage, Articular; Disease Models, Animal; Metformin; Mice; Nicotinamide Phosphoribosyltransferase; Osteoarthritis | 2023 |